国际眼科纵览 ›› 2026, Vol. 50 ›› Issue (4): 314-320.doi: 10.3760/cma.j.cn115500-20251217-26413

• 综述 • 上一篇    

头颈部肿瘤放射治疗后放射性视神经病变

撖玉盈1  魏世辉2  傅涛1   

  1. 1 首都医科大学附属北京天坛医院眼科,北京 100070;2 中国人民解放军总医院眼科,北京 100853
  • 收稿日期:2025-12-17 出版日期:2026-08-25 发布日期:2026-08-14
  • 通讯作者: 傅涛,Email:futao@bjtth.org
  • 基金资助:
    国家自然科学基金(82571253);北京市自然科学基金非共识创新项目(F251026);首都医科大学北京天坛医院科研项目(RCYJ -2024-04)

Radiation-induced optic neuropathy after radiotherapy for head and neck tumors

Han Yuying1, Wei Shihui2, Fu Tao1   

  1. 1 Department of Ophthalmology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China; 2 Department of Ophthalmology, The Chinese PLA General Hospital, Beijing 100853, China

  • Received:2025-12-17 Online:2026-08-25 Published:2026-08-14
  • Contact: Fu Tao, Email: futao@bjtth.org
  • Supported by:
    National Natural Science Foundation of China (82571253); Beijing Municipal Natural Science Foundation Non-Consensus Innovation Project (F251026); Research Project of Beijing Tiantan Hospital, Capital Medical University (RCYJ-2024-04)

摘要: 头颈部肿瘤往往紧邻视觉通路,放射治疗是其不可或缺的治疗手段,但也带来了严重的晚期视觉损害风险。放射性视神经病变(radiation-induced optic neuropathy,RION)是一种由辐射诱导的迟发性视神经及视交叉缺血性损伤,表现为急性或亚急性无痛性视力下降,可导致不可逆视力丧失,潜伏期数月至数年不等。其发生率与放射治疗技术及剂量密切相关,不同肿瘤的RION发生率也有所差异。病理机制目前尚不明确,可能与血管内皮损伤引发的缺血水肿、视神经纤维轴浆运输障碍等相关。RION的诊断是排除性诊断,在排除肿瘤复发等导致视力下降的疾病后,需结合病史、临床表现及影像学检查等综合分析判断。治疗以对症治疗为主,包括糖皮质激素、高压氧、抗VEGF治疗等,尚无特效疗法。本综述旨在系统阐述RION的概念、流行病学特征、影响因素、临床表现、诊断及治疗,为头颈部肿瘤放射治疗的临床决策与RION防治提供参考。

关键词: 放射性视神经病变, 头颈部肿瘤

Abstract: Tumors of the head and neck are often located adjacent to visual pathways. Radiotherapy is an indispensable treatment for these tumors, but it also carries a significant risk of severe delayed visual impairment. Radiation-induced optic neuropathy (RION) is a delayed, radiation-induced ischemic injury of the optic nerve and optic chiasm, characterized by acute or subacute painless vision loss that can lead to irreversible visual impairment. The latency period ranges from several months to years. The incidence of RION is closely associated with radiotherapy techniques and doses, varying among different tumor types. The pathogenesis of RION remains incompletely elucidated but is thought to involve vascular endothelial damage-induced ischemia and edema, as well as axoplasmic transport disruption in the optic nerve fibers. Diagnosis of RION is primarily one of exclusion, requiring the exclusion of other causes of vision loss, such as tumor recurrence, followed by a comprehensive analysis of medical history, clinical manifestations, and imaging findings. Current treatments for RION are mainly symptomatic, as no definitive cure exists. Options include corticosteroid therapy, hyperbaric oxygen therapy, and anti-vascular endothelial growth factor (anti-VEGF) therapy. This review aims to systematically elaborate on the concept, epidemiological characteristics, influencing factors, clinical manifestations, diagnosis, and treatment of RION, providing a reference for clinical decision-making in radiotherapy for head and neck tumors and the prevention and management of RION.

Key words: Radiation-induced optic neuropathy, Head and neck tumors